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Tuesday, March 3, 2009 529aintermembrane space of mitochondria. MAC is a potential therapeutic target, as
modulation of its opening could induce or prevent cell death. Compounds pre-
viously found to block Bax-induced release of fluorescein from liposomes were
tested for their ability to directly inhibit the channel activity of MAC. Patch
clamp techniques were applied to proteoliposomes containing mitochondrial
outer membranes of apoptotic FL5.12 cells to monitor MAC activity. Several
antagonists irreversibly blocked MAC with the IC50’s ranging from 25 to
900 nM. These Inhibitors of MAC, or iMACs, were also effective in preventing
cytochrome c release and progression of apoptosis induced by IL3 deprivation
or staurosporine treatment. A matrix-targeted GFP facilitated visualization of
the collapse of the mitochondrial network during staurosporine-induced apo-
ptosis; this collapse was also prevented by iMACs. The action of these inhib-
itors demonstrates the tight links between MAC activity, cytochrome c
release and apoptosis. Future studies will evaluate the impact of MAC on
mitochondrial dynamics.2721-Pos Board B691
Voltage-gated Potassium Channel In Brain Mitochondria
Krzysztof Dolowy1, Piotr Bednarczyk1,2, Joanna Kowalczyk3,
Adam Szewczyk2, Barbara Zablocka3.
1Warsaw University of Life Sciences - SGGW, Warszawa, Poland, 2Nencki
Institute of Experimental Biology, Warsaw, Poland, 3Mossakowski Medical
Research Institute, Warszawa, Poland.
Transient cerebral ischemia is known to induce endogenous adaptive mecha-
nisms such as the activation of mitochondrial ATP regulated potassium chan-
nels or Ca2þ regulated large conductance potassium channels that can prevent
or delay neuronal injury. In this study a single channel activity was measured
after patch-clamp of the mitoplasts isolated from gerbil hippocampus. In 70%
of the all patches, a potassium selective current was recorded with mean con-
ductance 1095 6 pS in symmetrical 150 mM KCl solution. The patch-clamp
single channel studies showed properties of the voltage-gated potassium chan-
nel (Kv channel). We found that ATP/Mg2þ complex and Ca2þ ions had no
effects on observed activity of ion channel. Observed channel was blocked
by negative voltage and margatoxin (MgTx) a specific Kv1.3 channel inhibitor.
The inhibition byMgTx was irreversible. We conclude that gerbil hippocampus
mitochondria contain voltage-gated potassium channel (mitoKv) with proper-
ties similar to the surface membrane Kv1.3 channel which can play a role
in control function of mitochondria as well as in ischemia-reperfusion phenom-
enon.
This study was supported by grant No. P-N/031/2006 and Polish Mitochondrial
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Large-conductance calcium-activated potassium (BK) channels are expressed
in the plasma membrane of various cell types. Interestingly, recent studies pro-
vide evidence for existence of this channel also in mitochondria. The goal of the
present study was to find a candidate for the regulatory component of the large
conductance calcium activated potassium channel in neurons. A combined
approach of western blot analysis, high-resolution immunofluorescence and
immunoelectron microscopy with the use of antibodies directed against four
distinct beta subunits demonstrated the presence of the BK channel beta4 sub-
unit in the inner membrane of neuronal mitochondria in rat brain and cultured
neurons. Additionally, channel activity was measured with the use of patch-
clamp technique.
The study was supported by grant from Ministry of Science and Higher Educa-
tion No P-N/031/2006 and Polish Mitochondrial Network MitoNet.pl.2723-Pos Board B693
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Bcl-2 can be converted into a pro-apoptotic molecule by nuclear receptor
Nur77. The development of Bcl-2 converters as anti-cancer therapeutics
has been explored by us. We reported recently the identification of
a Nur77-derived Bcl-2 converting peptide (NuBCP) and its enantiomer,
which induce apoptosis of cancer cells in vitro and in animals. The apoptotic
effect of NuBCP enantiomers and their activation of Bax are not inhibited
but rather potentiated by Bcl-2. Using fluorescence polarization assays, we
determined that NuBCP enantiomers bind both quantitatively and stoichio-
metrically to the Bcl-2 loop, which shares the characteristics of structurally
adaptable regions with many cancer-associated signaling proteins. NuBCP-9
enantiomers act as molecular switches to dislodge the Bcl-2 BH4 motif ex-
posing its BH3 motif. Mechanistically we demonstrated, using fluorescence
quenching based liposome assays, that NuBCP-9-induced Bcl-2 conforma-
tional change not only neutralizes Bcl-2’s inhibition of Bax-mediated mem-
brane permeabilization but also exposes the Bcl-2’s BH3 motif that in turn
neutralizes Bcl-XL’s inhibition of Bax like BH3 motif-derived peptides and
compounds. Our results provide mechanistic insight into Bcl-2 conversion
and identify a new direction for developing Bcl-2-based cancer therapeutics.
(This work is in part supported by the grant GM062964 to J. Lin from the
National Institute of Health.)2724-Pos Board B694
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We have studied mitochondrial bioenergetics in HL180 cells (a cybrid line har-
boring the T14484C/ND6 and G14279A/ND6 mtDNA mutations of Leber he-
reditary optic neuropathy, leading to an about 50% decrease of ATP synthesis)
and XTC.UC1 cells (derived from a thyroid oncocytoma bearing a disruptive
frameshift mutation in the MT-ND1 gene, which impairs complex I assembly).
Addition of rotenone to HL180 cells and of antimycin A to XTC.UC1 cells
caused fast mitochondrial membrane depolarization that was prevented by
treatment with cyclosporin A, intracellular Ca2þ chelators, and antioxidant.
Both cell lines also displayed an anomalous response to oligomycin, with rapid
onset of depolarization that was prevented by cyclosporin A and by overex-
pression of Bcl-2. These findings indicate that depolarization by respiratory
chain inhibitors and oligomycin was due to opening of the mitochondrial per-
meability transition pore (PTP). A shift of the threshold voltage for PTP open-
ing close to the resting potential may therefore be the underlying cause facil-
itating cell death in diseases affecting complex I activity. This study
provides a unifying reading frame for previous observations on mitochondrial
dysfunction, bioenergetic defects and Ca2þ deregulation in mitochondrial dis-
eases. Therapeutic strategies aimed at normalizing the PTP voltage threshold
may be instrumental in ameliorating the course of complex I-dependent mito-
chondrial diseases.2725-Pos Board B695
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Background: Bax is a pivotal pro-apoptotic Bcl-2 family protein that localizes
to the mitochondrial outer membrane (MOM) during apoptosis and causes
MOM permeabilization to proteins (MOMP). Earlier studies have demon-
strated that upon an apoptotic stimulus, ceramide levels often greatly increase
in cell membranes, including in the MOM. Elevation of ceramide in the MOM
is sufficient to cause MOMP without requiring Bcl-2 family proteins. Moreover
ceramide induced MOMP is reversed/prevented by the anti-apoptotic protein,
Bcl-xL.Methods: Using rat liver or yeast mitochondria, the MOMP was mea-
sured with a dynamic cytochrome c accessibility assay. Ceramide’s channel-
forming ability was also assessed using a defined system: planar phospholipid
membranes. Only C16-ceramide was used. Results:We found that Bax induces
MOMP by apparently enlarging ceramide channels. While ceramide forms
